专题:Relapsing Polychondritis and VEXAS Syndrome Research

This cluster of papers focuses on the research related to Relapsing Polychondritis, a rare autoimmune disease characterized by recurrent inflammation of cartilage and other tissues. It also encompasses studies on VEXAS syndrome, a recently identified autoinflammatory condition associated with somatic mutations in UBA1. The papers cover various aspects including clinical features, disease activity, therapeutic options, and the role of somatic mutations in these conditions.
最新文献
The predictive value of baseline systemic inflammation response index and systemic immune-inflammation index for the risk of infection within 6 months following initial immunosuppressive treatment in patients with ANCA-associated vasculitis

article Full Text OpenAlex

Exploring the Vasculitis‐Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications

article Full Text OpenAlex

Behçet's Disease: A Comprehensive Overview of Symptoms, Pathology, Genetics, and Treatment.

article Full Text OpenAlex

Easily Missed? Giant cell arteritis

article Full Text OpenAlex

Immune dysregulation diseases caused by somatic mutations

article Full Text OpenAlex

Dapsone Toxicity in Relapsing Polychondritis: Methemoglobinemia and Concomitant Hemolytic Anemia

article Full Text OpenAlex

Clinical and genomic features of Iranian patients with very early onset IBD

article Full Text OpenAlex

Macrophage Activation Syndrome Following Vaccination After HSCT

article Full Text OpenAlex

Long-term treatment patterns and outcomes in IgG4-related disease – a retrospective single-center cohort study focusing on rituximab

article Full Text OpenAlex

Kidney Transplantation in Childhood-Onset ANCA-Associated Vasculitis

article Full Text OpenAlex

近5年高被引文献
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis

article Full Text OpenAlex 324 FWCI47.5853

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

review Full Text OpenAlex 218 FWCI33.8384

Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population

article Full Text OpenAlex 213 FWCI54.6036

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

article Full Text OpenAlex 195 FWCI32.1778

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis

article Full Text OpenAlex 194 FWCI27.8171

2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis

article Full Text OpenAlex 174 FWCI24.6295

Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

article Full Text OpenAlex 165 FWCI27.0748

Behçet's syndrome

review Full Text OpenAlex 123 FWCI70.7461

Disorders of ubiquitylation: unchained inflammation

review Full Text OpenAlex 121 FWCI9.8993

Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial

article Full Text OpenAlex 111 FWCI16.2672